Essenvia - About the company
Essenvia is a series A company based in Los Angeles (United States), founded in 2018 by Basant Sahoo and Soumya Mahapatra. It operates as a Provider of regulatory information management (RIM) platform for the MedTech industry. Essenvia has raised $5.53M in funding from Benhamou Global Ventures and Wavemaker 360. The company has 51 active competitors, including 9 funded and 3 that have exited. Its top competitors include companies like RIMSYS, ValGenesis and Sware.
Company Details
Provider of regulatory information management (RIM) platform for the MedTech industry. The platform enables management of regulatory workflows across the total product lifecycle. It facilitates global market access and generates business value. The platform offers centralized repository for regulatory information, collaborative authoring, and reporting. It supports registrations, submissions, and change assessment. The platform automates regulatory change assessment to determine impact of change.
- Website
- essenvia.com
- Email ID
- *****@essenvia.com
- Registered Address
- No-11/A 12 5th Sector, HSR Layout, Bangalore, Bangalore, Karnataka, India, 560102
Key Metrics
Founded Year
2018
Location
Los Angeles, United States
Stage
Series A
Total Funding
$5.53M in 3 rounds
Latest Funding Round
Investors
Ranked
5th among 51 active competitors
Employee Count
9 as on Aug 31, 2025
Legal entities associated with Essenvia
Essenvia is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
Essenvia, Inc. CIN: 854368836 , United States, Active | - | 4 (As on Dec 31, 2024) | - | |
ESSENVIA SOLUTIONS PRIVATE LIMITED CIN: U72900KA2021PTC143568 , India, Active | Jan 27, 2021 | 0 - ₹10 Cr (As on Mar 31, 2025) | 9 (As on Aug 31, 2025) |
Sign up to download Essenvia's company profile
Essenvia's funding and investors
Essenvia has raised a total funding of $5.53M over 3 rounds. Its first funding round was on Mar 09, 2020. Essenvia has 9 institutional investors.
Here is the list of recent funding rounds of Essenvia:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Nov 15, 2023 | 7279399 | Series A | 1805670 | 8445324 | 5974422 | 8049898 |
Mar 07, 2023 | 6291955 | Seed | 6344905 | 2079462 | 4628748 | |
Mar 09, 2020 | 5426382 | Seed | 8537438 | 4722182 | 2360208 |
View details of Essenvia's funding rounds and investors
Essenvia's founders and board of directors
Founder? Claim ProfileThe founders of Essenvia are Basant Sahoo and Soumya Mahapatra. Soumya Mahapatra is the CEO of Essenvia.
Here are the details of Essenvia's key team members:
- Basant Sahoo: Founder & CEO of Essenvia. Contact Info: 1 email address
- Soumya Mahapatra: Founder & CEO of Essenvia.
View details of Essenvia's Founder profiles and Board Members
Essenvia's employee count trend
Essenvia has 9 employees as of Aug 25. The total employee count is 31.0% lower than what it was in Aug 24. Here is Essenvia's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Essenvia's Competitors and alternates
Top competitors of Essenvia include RIMSYS, ValGenesis and Sware. Here is the list of Top 10 competitors of Essenvia, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | RIMSYS 2017, Pittsburgh (United States), Series A | Provider of medical device regulatory management software for healthcare organizations | $25.8M | 60/100 | |
2nd | ValGenesis 2005, Fremont (United States), Series B | Validation software for the life sciences companies | $24M | 55/100 | |
3rd | Sware 2015, Chelsea (United States), Series B | Provider of a platform for validation automation for regulated systems | $26.4M | 43/100 | |
4th | Clinical.ly 2017, New York City (United States), Seed | Provider of a software solution for regulatory compliance | $1.08M | - | 42/100 |
5th | Essenvia 2018, Los Angeles (United States), Series A | Provider of regulatory information management (RIM) platform for the MedTech industry | $5.53M | 41/100 | |
6th | iContracts 2007, Raritan (United States), Acquired | Provider of enterprise software for life sciences compliance and revenue operations | $4M | 41/100 | |
7th | Rescop 2005, Eindhoven (Netherlands), Funding Raised | Rescop offers regulatory and quality management solutions and consultancy services. | - | 39/100 | |
8th | Provider of data to companies that develop medical algorithms | - | 35/100 | ||
9th | Samarind 1987, Deeside (United Kingdom), Acqui-Hired | Provider of software solutions in the life sciences and other sectors | - | - | 32/100 |
10th | Target Health 1993, New York City (United States), Acquired | Full-service e*CRO optimizing drug, biologic, and device lifecycles | - | - | 32/100 |
Looking for more details on Essenvia's competitors? Click here to see the top ones
Essenvia's Investments and acquisitions
Essenvia has made no investments or acquisitions yet.
Reports related to Essenvia
Here is the latest report on Essenvia's sector:
News related to Essenvia
•
•
Shima Capital Leads $8M Funding Round for Hard Wallet Solutions Provider TangemNftgators•May 03, 2023•Essenvia, Benhamou Global Ventures, First Rays Venture Partners, Rebright Partners and 6 others
•
Essenvia Raises $4M in Pre-Series A RoundFinSMEs•May 03, 2023•Essenvia, Benhamou Global Ventures, First Rays Venture Partners, Rebright Partners and 2 others
Are you a Founder ?
FAQs about Essenvia
Explore our recently published companies
- Love Cosmedical - Italy based, Unfunded company
- Arvind - Unfunded company
- KONARK FIXTURES - India based, Unfunded company
- Athletes' Ink - 2017 founded, Unfunded company
- Weave - Unfunded company
- Art Sites - 2014 founded, Unfunded company
